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INTRODUCTION 
Metformin hydrochloride is a biguanide antihyperglycemic 
drug, which is orally used in the management of 
noninsulin-dependent diabetes mellitus (NIDDM or Type 
II diabetes mellitus) alone or in combination with other 
hypoglycemic agents. Its antihyperglycemic effect is due 
to the metabolic activities at several sites (biophase), 
including liver, intestinal cells, and adipocytes1, 2, 3. It has a 
short biological half-life of 1.5–1.6 h and the daily 
requirement of it is 1.5–3 g/day. Therefore, the marketed 
immediate release product needs to be administered 2- 3 
times daily to maintain effective plasma concentration 4. 
So that, there being high incidence of gastrointestinal side 
effects and toxicity. These drawbacks can be overcome by 
designing suitable sustained release Metformin 
hydrochloride formulations. Administration of a sustained 
Metformin hydrochloride release dosage form could 
reduce the dosing frequency and improve the patient 
compliance 1.  
Among various oral sustained drug delivery systems, 
polymeric microparticles are one of the options and have 
been studied in past few decades in order to deliver drug 
molecules to the target site with specificity with several 
advantages like better oral bioavailability of drugs, 
reduction in side effects, decreased dosing frequency, and 
hence, improved patient compliance 5, 6, 7. 
Microparticles are solid, approximately spherical particles 
ranging in size from 1 to 1000 μm. They are made up of 
polymeric substances, in which the drug molecules are 
dispersed, entrapped, or adsorbed in the polymeric matrix. 
Microparticles are sometimes referred to as Microspheres, 
and other synonymous words are micro beads, beads and 
microcapsules 8. 
The objective of present investigation is to prepare 
sustained release water soluble microparticles of 
Metformin hydrochloride using different drug polymer 
ratio and different concentration of the surface-active agent 
in the liquid paraffin medium applying a variable rotating 
speed of the electrical stirrer, evaluation of the prepared 
microparticles and also the comparison of drug release in 
in-vitro condition from the different batches of prepared 
microparticles.  
MATERIALS AND METHODS 
Drugs & Chemicals: Metformin hydrochloride was 
received from Zydus Cadila Health Care Ltd; Ahmedabad, 
Ethyl cellulose (S.D. Fine-Chem. Ltd., Mumbai), 
Methanol (Finar Chemical Ltd., Ahmedebad), Acetone 
(Merck Specialities Pvt. Ltd., India), Liquid Paraffin 
(Merck Specialities Pvt. Ltd., India), Span 80 (Ranbaxy 
Fine Chemicals Ltd., India) , Petroleum ether (Merck 
Specialities Pvt. Ltd., India). All the chemicals were of 
analytical grade, obtained commercially and were used 
without further purification.  
Instruments used: UV-VIS Spectrophotometer (Model 
No. UV-1700 Pharmaspec, SHIMADZU, Japan), Single 
stage Dissolution Apparatus (Electrolab), Single pan 
Electronic Balance (Model No.160D, Dhona Instruments 
Pvt. Ltd. Kolkata), Digital Stirrer (Remi Motors and 
Equipments), Hot air Oven (Sisco, Thane East, 
Maharashtra) Digital PH Meter (Model No. MK-VI, 
Systronics, Ahmedabad). 
Preparation of microparticles
1
: Ethyl cellulose 
microparticles containing Metformin hydrochloride were 
prepared by emulsification- solvent evaporation technique 
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varying various formulation variables. Briefly, the drug, 
Metformin hydrochloride was mixed in methanol and ethyl 
cellulose was mixed in acetone at various drug-polymer 
ratios. Then, these two were mixed properly, and the slurry 
was slowly introduced into 50mL of liquid paraffin 
containing Span 80 (variable percentage) as stabilizer and 
stirred (600 to 900 rpm) by a mechanical stirrer equipped 
with a three bladed propeller at room temperature for 2hr 
to allow the solvent to evaporate completely and the 
formed microparticles were collected by filtration. The 
microparticles were washed repeatedly with petroleum 
ether (40–60 ⁰C) until free from oil. 
 
Table 1: Formulation parameters used in the preparation of microparticles 
FORMULATION CODE DRUG:POLYMER RATIO STIRRER SPEED (RPM) SURFACTANT (SPAN80)  
CONC. (%) 
F-1 1:2 600- 900 4 % 
F-2 1:3 600- 900 4% 
F-3 1:4 600- 900 4% 
F-4 1:5 600- 900 4% 
F-5 1:5 600- 900 2% 
 
Evaluation of prepared microparticles
 8, 9, 10, 11
: 
(A)  Bulk density: A known quantity of powder was 
poured into the measuring cylinder carefully level the 
powder without compacting, if necessary and read the 
unsettled apparent volume Vo, to the nearest graduated 
unit . Calculate the bulk density, in gm per ml, by the 
formula m / Vo. 
(B) Tapped density: Tapped density is achieved by 
mechanically tapping a measuring cylinder containing a 
powder sample. Cylinder dropping distance 14± 2 mm at a 
normal rate of 300 drops / minute. Unless otherwise 
specified, tab the cylinder 500 times initially and measure 
the tapped volume, Va, to the nearest graduated unit. 
Repeat the tapping an additional 750 times and measure 
the tapped volume, Vb, to the nearest graduated unit. 
Tapped Density = M/V. 
(C)  Carr's Compressibility Index: The Carr‟s 
index (also: Carr's index or Carr's Compressibility Index is 
an indication of the compressibility of a powder. It is 
named after the pharmacologist Charles Jelleff Carr 
(1910–2005). The Carr index is calculated by 
the formula, C= 100 × (VB-VT)/VB; where, VB is the freely 
settled volume of a given mass of powder, and VT is the 
tapped volume of the same mass of powder. It can also be 
expressed as C= 100× (1-ρB/ρT), where, ρB is the freely 
settled bulk density of the powder, and ρT is the tapped 
bulk density of the powder. The Carr index is frequently 
used in pharmaceutics as an indication of the flowability of 
a powder. A Carr index greater than 25 is considered to be 
an indication of poor flowability, and below 15, of good 
flowability. 
(D)  Hausner ratio: The Hausner ratio is a number 
that is correlated to the flowability of a powder or granular 
material. It is named for the engineer Henry H. Hausner 
(1900–1995). The Hausner ratio is calculated by the 
formula, H= ρT/ ρB; where ρB is the freely settled bulk 
density of the powder, and ρT is the tapped bulk density of 
the powder. The Hausner ratio is not an absolute property 
of a material; its value can vary depending on the 
methodology used to determine it. 
(E)  Angle of Repose: The angle of repose or more 
precisely the critical angle of repose of a granular 
material is the steepest angle of descent or dip of the slope 
relative to the horizontal plane when material on the slope 
face is on the verge of sliding. This angle is in the range 
0°–90°. When bulk granular materials are poured onto a 
horizontal surface, a conical pile will form. The internal 
angle between the surface of the pile and the horizontal 
surface is known as the angle of repose and is related to 
the density, surface area and shapes of the particles, and 
the coefficient of friction of the material. Generally 25-30⁰ 
exhibits good flow property.  
(F) Determination of percentage Yield: 
Microcapsules dried in vacuum desscicator were then 
weighed and yield of microcapsules was calculated using 
following formula:  
Percent yield = The amount of microcapsules obtained/The 
theoretical amount x100. 
(G)  Entrapment Studies: Drug entrapment 
efficiency of Metformin HCl microparticles was 
performed by accurately weighing 50 mg of microparticles 
and suspended in 100ml of PBS of pH7.4 and it was kept 
aside for 24 hours. Then, it was stirred for 15 mins and 
filtered. After suitable dilution, Metformin HCl content in 
the filtrate was analyzed spectrophotometrically at 232 nm 
using U.V. spectrophotometer.  
Percent yield = Estimated drug content/ Theoretical Drug 
content × 100. 
(H)  In-vitro drug release studies: Release of 
Metformin HCl from separate formulations was studied by 
taking phosphate buffer (pH-7.4) solution as dissolution 
media. Dissolution assays for each batch for separate drugs 
were carried out in triplicate to get reproducible results and 
the assay procedure was carried out till the drug release 
was almost constant from the prepared devices. The tests 
were performed into an apparatus as described in USP 
.The sample holder consisting of 100mg of microcapsules 
containing plain Metformin HCl. The Agitation speed was 
maintained at 100 rpm. At prefixed time (15 min, 30min, 
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60min, 90min, 120min and then at 1hrs. interval onwards), 
5ml of solution were withdrawn and replenished with 
dissolution medium kept at constant temperature of 370c 
and the solutions were filtered by using 0.45μ membrane 
filter and spectrophotometrically assayed for the 
Metformin HCl content in the various formulations (at, = 
232 nm).The drug release rates were plotted as a function 
of time (in hours) versus percent (%) release.  
 
Preparation of calibration curve of Metformin 
hydrochloride  
At first 100 mg of Metformin  HCl was weighed out in a 
100ml volumetric flask and to this flask, 100ml phosphate 
buffer (6.8 pH) was added and then from this stock 
solution of prepared concentration of 1mg/ml, taken 1ml of 
solution in a volumetric flask of 100ml capacity and 
diluted the solution to 100ml which gave a concentration 
of 10 μg/ml and this process was repeated to obtain 
concentration of 20 μg/ml, 30 μg/ml, 40 μg/ml and 50 
μg/ml by taking respectively 2ml, 3ml, 4ml and 5ml from 
the stock solution. Thus the absorbance of the prepared 
solutions was measured in a UV-VIS spectrophotometer.  
RESULTS AND DISCUSSION 
(A) Table 2: Bulk density. 
FORMULATION CODE BULK DENSITY (g/cm3) 
F-1 0.324 
F-2 0.49 
F-3 0.82 
F-4 0.632 
F-5 0.51 
 
(B) Table 3: Tapped density. 
FORMULATION CODE TAPPED DENSITY 
(g/cm3) 
F-1 0.54 
F-2 0.552 
F-3 0.93 
F-4 0.665 
F-5 0.55 
 
(C) Table 4: Carr's Compressibility Index. 
FORMULATION CODE CARR‟S 
COMPRESSIBILITY INDEX 
(%) 
F-1 40.7 
F-2 11.27 
F-3 11.82 
F-4 4.87 
F-5 7.27 
(D) Table 5: Hausner ratio. 
FORMULATION CODE HAUSNER RATIO 
F-1 1.687 
F-2 1.12 
F-3 1.13 
F-4 1.05 
F-5 1.07 
 
(E) Table 6: Angle of Repose.  
FORMULATION CODE ANGLE OF REPOSE (θ) 
F-1 43⁰53' 
F-2 41⁰98' 
F-3 36⁰86' 
F-4 32⁰12' 
F-5 32⁰2' 
 
(F) Table 7: Determination of percentage yield. 
FORMULATION CODE PERCENTAGE YIELD 
(%) 
F-1 59.66 
F-2 61.25 
F-3 62.12 
F-4 41.2 
F-5 68.58 
 
(G) Table 8: Drug Entrapment Studies. 
FORMULATION CODE PERCENTAGE 
ENTRAPMENT (%) 
F-1 65.56 
F- 2 62.55 
F-3 51.04 
F- 4 41.40 
F- 5 68.92 
 
(H) Table 9: Calibration Curve for Metformin 
HCL. 
 
 
 
 
 
 
CONC ( μg /ml) ABSORBANCE 
10  μg /ml 0.063 
20 μg /ml 0.170 
30 μg /ml 0.272 
40 μg /ml 0.380 
50 μg /ml 0.431 
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(I) Table 10: In-vitro drug release studies. 
S. NO TIME IN HRS F- 1 F- 2 F- 3 F- 4 F- 5 
1 1 8.103 10.105 10.232 14.106 11.452 
2 2 12.192 14.109 13.482 17.178 16.819 
3 3 17.185 20.190 21.456 25.627 27.879 
4 4 26.654 28.104 26.543 29.105 31.764 
5 5 35.012 37.687 40.432 35.912 42.564 
6 6 45.074 48.670 51.453 50.876 52.789 
7 7 57.798 60.321 63.145 62.389 64.456 
8 8 72.102 73.452 70.145 68.568 70.342 
 
 
Water soluble Metformin hydrochloride was being 
prepared by ethylcellulose in liquid paraffin medium with 
variable rotating speed, drug polymer ratio and different 
ratio of the surfactant. Percentage yield been found 
between 57 to 73% and the percentage entrapment is found 
between 41.2 to 68.58% .The bulk density been found 
between 0.324 to 0.82 (g/cm3), tapped density between 
0.54 to 0.93 (g/cm3), The Carr‟s compressibility between 
4.87 to 40.7 %. Hausner ratio came between 1.05 to 1.68. 
Angle of repose noted between 32⁰2' to 43⁰53'. In release 
study it was seen that the water soluble Metformin HCL 
microspheres are giving good sustained effect as the 
release after 8 hours are noted near about 70% in 
maximum cases. Here it was observed that when the 
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amount of polymer is increased and the concentration of 
the surfacting agent been decreased the microparticles are 
coming in good spherical shape with a standard particle 
size.  
CONCLUSIONS 
From the above findings of the present investigations, it 
was evident that the selected materials and sustained 
release property offering very promising area in the field 
of research .This field is wide open for the researchers to 
work on this material on designing of drug delivery 
devices. This will lead to a new application of the specified 
drug (Metformin HCl) in the field of controlled drug 
delivery system.  
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